NASDAQ •
Healthcare •
Biotechnology •
Quote as of 06/08/2026 10:44
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization32,172 mln
Float410 mln
Earnings Date08/12/2026
EPS
1.90
Moderate
P / E
29.41
Elevated
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.94
Likely reliable
1-Year Forecast
59.25
Modest upside
Relative Strength
79
/ 100
Strongly outperforming
Business Description
Royalty Pharma is a New York-based company that purchases royalty interests from drug developers and provides funding to advance new medicines. Founded in 1996, it holds royalty stakes in dozens of approved and pipeline treatments spanning areas such as cancer, rare diseases, neuroscience, and diabetes. This model allows the company to generate returns while helping bring important therapies to patients.
